Metraipolis › archive › dc_2c9332cf7cd9

Naringenin as a neurotherapeutic agent in Alzheimer's disease: epigenetic signatures, gut microbiota alterations, and molecular neuroprotection — Europe PMC PMID:40893127

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40893127
DOI
10.3389/fnagi.2025.1647967
License (as archived)
solo-consultazione
Archived
2026-11-10T14:59:02.787Z
SHA-256 of the archived text
a2c335e8078eadcbd4613d06dda96c7f464177df70a301e256706c48e45f730a
Stable URL of this page
https://metraipolis.com/documento/dc_2c9332cf7cd9

How to cite

Naringenin as a neurotherapeutic agent in Alzheimer's disease: epigenetic signatures, gut microbiota alterations, and molecular neuroprotection — Europe PMC PMID:40893127 — Europe PMC (en), https://europepmc.org/article/MED/40893127 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2c9332cf7cd9 (Metraipolis archive dc_2c9332cf7cd9, sha256 a2c335e8078eadcbd4613d06dda96c7f464177df70a301e256706c48e45f730a)
BibTeX
@misc{dc2c9332cf7cd9,
  title = {Naringenin as a neurotherapeutic agent in Alzheimer's disease: epigenetic signatures, gut microbiota alterations, and molecular neuroprotection — Europe PMC PMID:40893127},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40893127},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2c9332cf7cd9; sha256 a2c335e8078eadcbd4613d06dda96c7f464177df70a301e256706c48e45f730a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40893127. Agents can read the archived copy with the MCP tool read_document.